Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

There is an urgent need for antiviral agents that treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We screened a library of 1900 clinically safe drugs against OC43, a human beta coronavirus that causes the common cold, and evaluated the top hits against SARS-CoV-2. Twent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2021-08, Vol.373 (6557), p.931-936
Hauptverfasser: Drayman, Nir, DeMarco, Jennifer K, Jones, Krysten A, Azizi, Saara-Anne, Froggatt, Heather M, Tan, Kemin, Maltseva, Natalia Ivanovna, Chen, Siquan, Nicolaescu, Vlad, Dvorkin, Steve, Furlong, Kevin, Kathayat, Rahul S, Firpo, Mason R, Mastrodomenico, Vincent, Bruce, Emily A, Schmidt, Madaline M, Jedrzejczak, Robert, Muñoz-Alía, Miguel Á, Schuster, Brooke, Nair, Vishnu, Han, Kyu-Yeon, O'Brien, Amornrat, Tomatsidou, Anastasia, Meyer, Bjoern, Vignuzzi, Marco, Missiakas, Dominique, Botten, Jason W, Brooke, Christopher B, Lee, Hyun, Baker, Susan C, Mounce, Bryan C, Heaton, Nicholas S, Severson, William E, Palmer, Kenneth E, Dickinson, Bryan C, Joachimiak, Andrzej, Randall, Glenn, Tay, Savaş
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!